awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36689156-672E463C-F44D-4E3B-B0F6-104EE9EB2EB6
Q36689156-672E463C-F44D-4E3B-B0F6-104EE9EB2EB6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36689156-672E463C-F44D-4E3B-B0F6-104EE9EB2EB6
Role of immunochemotherapy in the treatment of chronic lymphocytic leukemia.
P2860
Q36689156-672E463C-F44D-4E3B-B0F6-104EE9EB2EB6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36689156-672E463C-F44D-4E3B-B0F6-104EE9EB2EB6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fa83293e5920aeaa4bcea17647ca79de12dfd99b
P2860
Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL).